La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « P. H. Yu »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P. H. Weiss < P. H. Yu < P. Hajos  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
003793 (2001) K. Tieu [Canada] ; P. C. Ashe [Canada] ; D. M. Zuo [Canada] ; P. H. Yu [Canada]Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes
004079 (1998) P. H. Yu [Canada] ; X. Zhang [Canada] ; D. M. Zuo [Canada] ; C. T. Lai [Canada] ; K. Tieu [Canada] ; B. A. Davis [Canada] ; A. A. Boulton [Canada]Aliphatic N-methylpropargylamines as potential neurorescue agents
004295 (1997) C.-T. Lai [Canada] ; P. H. Yu [Canada]R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells
004326 (1997) C.-T. Lai [Canada] ; P. H. Yu [Canada]Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells : effects of oxidative stress and antioxidative factors
004529 (1996) X. Zhang [Canada] ; D. Zuo [Canada] ; B. A. Davis [Canada] ; A. A. Boulton [Canada] ; P. H. Yu [Canada]Immunohistochemical evidence of neuroprotection by R(−)‐deprenyl and N‐(2‐hexyl)‐N‐methylpropargylamine on DSP‐4‐induced degeneration of rat brain noradrenergic axons and terminals
004642 (1995) J. Fang [Canada] ; D. M. Zuo [Canada] ; P. H. Yu [Canada]Lack of protective effect of R(-)-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasone
004701 (1995) X. Zhang [Canada] ; P. H. Yu [Canada]Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl
004755 (1995) J. Fang [Canada] ; P. H. Yu [Canada] ; A. A. Boulton [Canada] ; J. W. Gorrod [Royaume-Uni]Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia
004773 (1995) J. Fang [Canada] ; P. H. Yu [Canada]Effect of haloperidol and its metabolites on dopamine and noradrenaline uptake in rat brain slices
004782 (1995) J. Fang [Canada] ; D. Zuo [Canada] ; P. H. Yu [Canada]Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N -methyl-4-phenylpyridinium (MMP+) towards cultured dopaminergic neuroblastoma cells
004933 (1994) J. Fang [Canada] ; P. H. Yu [Canada]Effect of l-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake
004A62 (1994) P. H. Yu [Canada]Pharmacological and clinical implications of MAO-B inhibitors
005467 (1989) L. Hertz [Canada] ; L. Peng [Canada] ; E. Hertz [Canada] ; B. H. J. Juurlink [Canada] ; P. H. Yu [Canada]Development of monoamine oxidase activity and monoamine effects on glutamate release in cerebellar neurons and astrocytes

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "P. H. Yu" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "P. H. Yu" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    P. H. Yu
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022